{"title":"Knockdown of ITIH4 reduces inflammatory damage and apoptosis of A549 cells induced by <i>Mycoplasma pneumoniae</i> through NLRP3 inflammation.","authors":"Zhinan Zhang, Yixian Zhang, Bihe Zeng","doi":"10.15586/aei.v53i4.1367","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Mycoplasma pneumoniae (MP) is a leading cause of community-acquired respiratory infections in pediatric patients. This study aimed to investigate whether the pro-inflammatory function of inter-alpha-trypsin inhibitor heavy chain (ITIH4) contributes to the pathogenesis of MP-induced pneumonia.</p><p><strong>Method: </strong>A549 cells were stimulated with MP to model pneumonia in vitro. ITIH4 expression was knocked down in A549 cells using lentiviral transfection. Cell viability was measured using the Cell Counting Kit-8 (CCK-8) assay, while cell apoptosis was assessed via flow cytometry. The concentrations of pro-inflammatory (IL-6, TNF-α) and anti-inflammatory (IL-10) cytokines were quantified using enzyme-linked immunosorbent assay (ELISA). Western blotting was conducted to detect apoptosis-related proteins and components of the NLRP3 inflammasome.</p><p><strong>Result: </strong>MP stimulation led to increased ITIH4 expression in A549 cells, and knockdown of ITIH4 prevented the MP-induced reduction in cell viability. Moreover, ITIH4 knockdown reduced the release of inflammatory cytokines in response to MP and significantly decreased MP-induced apoptosis. In addition, ITIH4 knockdown inhibited activation of the NLRP3 inflammasome, while reactivation of NLRP3 reversed the protective effects associated with ITIH4 knockdown.</p><p><strong>Conclusion: </strong>ITIH4 knockdown alleviates MP-induced inflammatory damage and cell death in A549 cells by inhibiting activation of the NLRP3 inflammasome.</p>","PeriodicalId":7536,"journal":{"name":"Allergologia et immunopathologia","volume":"53 4","pages":"14-20"},"PeriodicalIF":2.1000,"publicationDate":"2025-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Allergologia et immunopathologia","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.15586/aei.v53i4.1367","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q3","JCRName":"ALLERGY","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Mycoplasma pneumoniae (MP) is a leading cause of community-acquired respiratory infections in pediatric patients. This study aimed to investigate whether the pro-inflammatory function of inter-alpha-trypsin inhibitor heavy chain (ITIH4) contributes to the pathogenesis of MP-induced pneumonia.
Method: A549 cells were stimulated with MP to model pneumonia in vitro. ITIH4 expression was knocked down in A549 cells using lentiviral transfection. Cell viability was measured using the Cell Counting Kit-8 (CCK-8) assay, while cell apoptosis was assessed via flow cytometry. The concentrations of pro-inflammatory (IL-6, TNF-α) and anti-inflammatory (IL-10) cytokines were quantified using enzyme-linked immunosorbent assay (ELISA). Western blotting was conducted to detect apoptosis-related proteins and components of the NLRP3 inflammasome.
Result: MP stimulation led to increased ITIH4 expression in A549 cells, and knockdown of ITIH4 prevented the MP-induced reduction in cell viability. Moreover, ITIH4 knockdown reduced the release of inflammatory cytokines in response to MP and significantly decreased MP-induced apoptosis. In addition, ITIH4 knockdown inhibited activation of the NLRP3 inflammasome, while reactivation of NLRP3 reversed the protective effects associated with ITIH4 knockdown.
Conclusion: ITIH4 knockdown alleviates MP-induced inflammatory damage and cell death in A549 cells by inhibiting activation of the NLRP3 inflammasome.
期刊介绍:
Founded in 1972 by Professor A. Oehling, Allergologia et Immunopathologia is a forum for those working in the field of pediatric asthma, allergy and immunology. Manuscripts related to clinical, epidemiological and experimental allergy and immunopathology related to childhood will be considered for publication. Allergologia et Immunopathologia is the official journal of the Spanish Society of Pediatric Allergy and Clinical Immunology (SEICAP) and also of the Latin American Society of Immunodeficiencies (LASID). It has and independent international Editorial Committee which submits received papers for peer-reviewing by international experts. The journal accepts original and review articles from all over the world, together with consensus statements from the aforementioned societies. Occasionally, the opinion of an expert on a burning topic is published in the "Point of View" section. Letters to the Editor on previously published papers are welcomed. Allergologia et Immunopathologia publishes 6 issues per year and is included in the major databases such as Pubmed, Scopus, Web of Knowledge, etc.